Leap Therapeutics
LPTX
LPTX
50 hedge funds and large institutions have $55M invested in Leap Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.09% less ownership
Funds ownership: 4.19% → 4.1% (-0.09%)
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.45M | |
| 2 | +$835K | |
| 3 | +$393K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$292K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$278K |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$1.56M | |
| 3 | -$1.01M | |
| 4 |
Renaissance Technologies
New York
|
-$829K |
| 5 |
6CM
683 Capital Management
New York
|
-$733K |